Associations
The American Cancer Society has awarded a $20,000 grant to Kingman Regional Medical Center's WL Nugent Cancer Center to provide transportation assistance to people with cancer during treatment. This grant is part of a nationwide investment of $9 million, which is expected to provide nearly 63,000
Associations
A large-scale telestroke network in Pennsylvania and a university medical center in Rhode Island have shown promising results in addressing racial and socioeconomic disparities in stroke treatment and recovery. Researchers presented three studies at the Society of NeuroInterventional Surgery's 22nd Annual Meeting, highlighting the impact of telestroke care
Associations
Riverside Healthcare has been recognized for its commitment to improving care for patients with aortic stenosis, a serious and common heart valve disease affecting over 1.7 million Americans over the age of 65. The hospital's dedication to optimizing treatment pathways and providing timely and appropriate treatment has
Associations
The American Association of Critical-Care Nurses (AACN) has announced its Board of Directors for fiscal year 2026, with terms effective July 1, 2025. The board leadership includes Rebekah Marsh as president, Tonka Williams as president-elect, and Sara Knippa as secretary. Rebekah Marsh, a clinical nurse educator at Harborview Medical Center,
Diseases
A recent study published in Biomedicines has shed light on the potential of FAPi PET/CT imaging in identifying fibrosis in immune-mediated inflammatory diseases (IMIDs). Researchers from Amsterdam University Medical Centers have conducted a comprehensive review of available evidence on FAPi PET/CT imaging in various IMIDs, including interstitial lung
Diseases
Investigators at Columbia University Medical Center have published a new report on autoimmunity, shedding light on the mechanisms behind human immune system diseases. According to the research, human immune system mice constructed with various methods are widely used for investigations of human immune responses to pathogens, transplants, and immunotherapies. The
Diseases
Recent research has shed light on the outcomes of liver transplant recipients with hepatocellular carcinoma (HCC) in the post-DAA (direct-acting antivirals) era. A study, conducted by researchers at Beth Israel Deaconess Medical Center, found that etiologies of HCC in liver transplant recipients had a significant impact on waitlist dropout and
Diseases
A breakthrough study published in the journal HemaSphere has demonstrated the effectiveness of a 12-color flow cytometric Minimal Residual Disease (MRD) protocol in detecting B-cell precursor Acute Lymphoblastic Leukemia (BCP-ALL). This new protocol, developed by the EuroFlow Consortium, expands on the existing 8-color flow cytometric MRD protocol and includes additional
Diseases
Researchers at Amsterdam University Medical Center in the Netherlands have been investigating the use of ambroxol hydrochloride (AMB) as a potential treatment for neurological manifestations in Gaucher disease type 3 (GD3). Gaucher disease is a rare genetic disorder that affects the body's ability to break down certain lipids,
Beth Israel Deaconess Medical Center
Researchers at Beth Israel Deaconess Medical Center (BIDMC) have successfully validated an artificial intelligence tool that detects severe aortic stenosis (AS) with over 98 percent accuracy. The tool, artificial intelligence decision support algorithm (AI-DSA), uses routine echocardiographic reports to predict an individual's probability of having severe AS. This
Hospitals
Research conducted at the Erasmus University Medical Center in Rotterdam, Netherlands, has found a strong association between elevated admission glucose levels and increased mortality in patients after a heart attack. The study, published in the American Journal of Cardiology, examined temporal trends in mortality after myocardial infarction from 1985 to
Hospitals
Gene therapy has the potential to provide therapeutic benefits to hepatocellular carcinoma (HCC) patients, but its efficiency and selectivity in delivering genetic material to tumor tissue remain a significant challenge. Despite extensive research, including various delivery techniques such as intravenous, intra-arterial, and intra-tumoral injections, a highly effective gene therapy for
